Patent 11518983 was granted and assigned to Invizyne on December, 2022 by the United States Patent and Trademark Office.
The present disclosure relates to recombinant prenyltransferase enzymes with increased thermostability and activity and the use of these enzymes in compositions and methods for biosynthesis involving prenylation reactions, including compositions and methods for the preparation of cannabinoids.